Appendix A
Clinical Practice Guidelines (CPG) Project Questionnaire
Please Circle the Correct Answer.
Year of Training (please circle): 1; 2; 3
Last four digits of your SS number:______
Knowledge Questions
Please Circle the Correct answer.
1)The High Normal BP (mmHg) Stage from the JNC-6 CPG is which of the following:
a)140-159/90-99
b)135-139/85-89
c)129-134/80-84
d)155-160/99-110
e)none of the above
2)The NCEP III CPG describes the following lipid levels except:
a)100 mg/dl LDL- Optimal
b)<30 mg/dl HDL –Low
c)200-499 mg/dl Triglyceride- High
d) 130-159 mg/dl- Borderline High
e)all of the above are correct
*Question 2 was omitted from the study due to a lipid type error in question 2(d).
3)The NCEP III CPG suggests that for a patient in the Optimal LDL category, a complete fasting lipid profile be obtained:
a)Each year as part of the annual HME (health maintenance exam)
b)Every two years
c)A random Total Cholesterol and HDL is preferred
d)Every ten years
e)Every five years
4)According to the NCEP III CPG recognizes the importance of Metabolic Syndrome (syndrome X) as a secondary target of therapy after recommended LDL levels are achieved. Which of the following is not a risk factor for Metabolic Syndrome:
a)Hypertension
b)Abdominal obesity
c)Triglyceride levels
d)Hyperglycemia
e)Hyperthyroidism
f)None of the above
5)The JNC-6 CPG suggests the use of all of the following anti-hypertensive medications have favorable effects on individuals with comorbid conditions except:
a)Angina: B-blockers, Calcium antagonists (CA);
b)DM II: Low dose diuretics
c)Dyslipidemia: B-blockers (non-ISA)
d)Heart failure: ACE I, diuretics
e)Dyslipidemia: alpha-blockers
6)The JNC-6 CPG describes Target Organ Damage (TOD)/Clinical Cardiovascular disease (CCD) as all of the following except:
a)Heart Failure
b)Retinopathy
c)Prior coronary revascularization
d)Stroke or Transient Ischemic Attack (TIA)
e)All of the above
7)The JNC-6 CPG suggests which of the following initial generalized treatment regimes:
a)Stage III, Risk Group A: Lifestyle modifications only
b)Stage I, Risk Group C: Lifestyle and drug therapy
c)Stage II, Risk group A: Lifestyle modifications only
d)High Normal, Risk Group B: Lifestyle and drug therapy
e)None of the above
8)NCEP III CPG suggests that any person with elevated LDL levels should undergo clinical evaluation to rule out all of the following causes of secondary hyperlipidemia except:
a)Diabetes
b)Obstructive Liver Disease
c)Drugs that increase LDL cholesterol and decrease HDL cholesterol
d)Nephrotic syndrome
e)Hyperthyroidism
9) NCEP III CPG describes a TG level of 200-499 as all of the following except:
a)An independent risk factor CHD risk factor
b)Priority treatment should be directed toward an LDL cholesterol goal
c)Described as a borderline high level
d)Weight reduction and increased physical activity are important treatment modalities
e)Often observed in individuals with metabolic syndrome
Attitude questions
Please circle the appropriate number
1- no knowledge/no utilization; 2- some knowledge/partial utilization; 3- good knowledge/partial utilization; 4- excellent knowledge/partial utilization; 5- excellent knowledge/constant utilization.
10) How well do you think that you know:
JNC-6 guidelines- 1; 2; 3; 4; 5
NCEP III guidelines- 1; 2; 3; 4; 5
11) Please circle the appropriate number for each question.
1- (strongly disagree) to 5-(strongly agree)
Do you think that your medical practice would benefit from knowing these CPGs?
1; 2; 3; 4; 5
12) Do you think that your patient population would benefit from the physician knowing these CPGs?
1; 2; 3; 4; 5
13) Please circle the appropriate answer.
What prevented you from learning and utilizing the JNC-6 and NCEP III guidelines? (please circle one or more)
a)Insufficient time;
b)A belief that your current knowledge is sufficient;
c)Inaccessibility of these guidelines for clinical reference;
d)Lack of critical appraisal ability;
e)Lack of instruction on CPG use;
f)Lack of faculty modeling;
g)Nothing;
h)Other: ______
14) Please circle the appropriate number. 1- (strongly disagree) to 5-(strongly agree)
Do you feel that you would benefit from the use of other CPGs, other than the JNC-6 and the NCEP III?
1; 2; 3; 4; 5
If you agree, which guidelines?
______
15) Do you think that being able to critically appraise a CPG is important?
1; 2; 3; 4; 5
16) Do you think that the chart reminder sheets make the guideline information more accessible to you?
1; 2; 3; 4; 5
17) Do you think that access to the actual CPG is as important as a well designed CPG chart reminder?
1; 2; 3; 4; 5
18) Do you think that a CPG chart reminder encourages you to learn, and utilize clinical guidelines?
1; 2; 3; 4; 5
1